[
    [
        {
            "time": "",
            "original_text": "沃森生物：子公司江苏沃森4价流感病毒裂解疫苗已处于临床阶段",
            "features": {
                "keywords": [
                    "沃森生物",
                    "子公司",
                    "江苏沃森",
                    "4价流感病毒裂解疫苗",
                    "临床阶段"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：子公司江苏沃森4价流感病毒裂解疫苗已处于临床阶段",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[互动]沃森生物：子公司4价流感病毒裂解疫苗已处于临床研究阶段",
            "features": {
                "keywords": [
                    "沃森生物",
                    "子公司",
                    "4价流感病毒裂解疫苗",
                    "临床研究阶段"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[互动]沃森生物：子公司4价流感病毒裂解疫苗已处于临床研究阶段",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-09",
            "original_text": "医药行业2020年1-9月疫苗批签发：流感疫苗大幅增加 创新疫苗继续高速增长",
            "features": {
                "keywords": [
                    "医药行业",
                    "2020年1-9月",
                    "疫苗批签发",
                    "流感疫苗",
                    "创新疫苗",
                    "高速增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2020年1-9月疫苗批签发：流感疫苗大幅增加 创新疫苗继续高速增长",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]